CHRISTINA TANSY: Open Payments
NPI 1528252418 · COLTON, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$9,272 in 316 payments from 42 companies in 2025. Trend: 2023 $6,607 · 2024 $7,877 · 2025 $9,272
Food & beverage: $8,704Education: $569
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 33 | $1,105 |
| Janssen Biotech, Inc. | 31 | $881 |
| Merck Sharp & Dohme LLC | 18 | $521 |
| Astellas Pharma US Inc | 19 | $507 |
| PFIZER INC. | 15 | $462 |
| ABBVIE INC. | 7 | $384 |
| Genentech USA, Inc. | 20 | $341 |
| Daiichi Sankyo Inc. | 5 | $310 |
| E.R. Squibb & Sons, L.L.C. | 15 | $287 |
| Novartis Pharmaceuticals Corporation | 20 | $273 |
Products named: KEYTRUDA, ERLEADA, Enhertu, VENCLEXTA, Trodelvy, RYBREVANT, OPDIVO, Vyloy.
Industry payments across CA — which companies pay providers there.
